MedTrace Logo

Minimizing Nausea and Vomiting During Spinals for CS

NCT02872935 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-06-09

Study results available
· View outcomes & findings →

Summary

In parturients undergoing Cesarean section under spinal anesthesia, co-loading of 1 liter of crystalloids, with placing the spinal, along with administering a phenylephrine infusion and glycopyrrolate, enables placing a spinal with minimal perioperative nausea and vomiting and good intra and post-operative pain relief.

Conditions

Interventions

DRUG

Glycopyrrolate

.2mg of Glycopyrrolate will be given intravenously with the administration of the spinal dose

DRUG

Normal Saline

1ml of normal saline will be given intravenously with the administration of the spinal dose

Sponsors & Collaborators

  • Kokila N Thenuwara

    lead OTHER

Principal Investigators

  • Kokila N Thenuwara, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-15
Primary Completion
2016-11-30
Completion
2016-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02872935 on ClinicalTrials.gov